Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 40 of 40 entries
Sorted by: Best Match Show Resources per page
Cirrhosis: Diagnosis and Management.

American family physician

Smith A, Baumgartner K, Bositis C.
PMID: 31845776
Am Fam Physician. 2019 Dec 15;100(12):759-770.

Cirrhosis is the 12th leading cause of death in the United States. Newer research has established that liver fibrosis is a dynamic process and that early cirrhosis may be reversible. Only one in three people with cirrhosis knows they...

Cite
Smith A, Baumgartner K, Bositis C. Cirrhosis: Diagnosis and Management. Am Fam Physician. 2019;100(12):759-770
Smith, A., Baumgartner, K., & Bositis, C. (2019). Cirrhosis: Diagnosis and Management. American family physician, 100(12), 759-770.
Smith, Andrew, et al. "Cirrhosis: Diagnosis and Management." American family physician vol. 100,12 (2019): 759-770.
Smith A, Baumgartner K, Bositis C. Cirrhosis: Diagnosis and Management. Am Fam Physician. 2019 Dec 15;100(12):759-770. PMID: 31845776.
Copy Download .nbib Format: NLM
[Present situation and prospect of diagnosis and treatment of rare complications of liver cirrhosis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Xu JH, Xu XY.
PMID: 32536049
Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):369-371. doi: 10.3760/cma.j.cn501113-20200418-00196.

Liver cirrhosis can lead to a variety of complications, among which few are relatively rare or overlooked despite being more common, and are thus termed "rare complications". However, these complications also affect the patient's prognosis, and need attention. This...

Cite
Xu JH, Xu XY. [Present situation and prospect of diagnosis and treatment of rare complications of liver cirrhosis]. Zhonghua Gan Zang Bing Za Zhi. 2020;28(5):369-371doi: 10.3760/cma.j.cn501113-20200418-00196.
Xu, J. H., & Xu, X. Y. (2020). [Present situation and prospect of diagnosis and treatment of rare complications of liver cirrhosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 28(5), 369-371. https://doi.org/10.3760/cma.j.cn501113-20200418-00196
Xu, J H, and Xu, X Y. "[Present situation and prospect of diagnosis and treatment of rare complications of liver cirrhosis]." Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology vol. 28,5 (2020): 369-371. doi: https://doi.org/10.3760/cma.j.cn501113-20200418-00196
Xu JH, Xu XY. [Present situation and prospect of diagnosis and treatment of rare complications of liver cirrhosis]. Zhonghua Gan Zang Bing Za Zhi. 2020 May 20;28(5):369-371. doi: 10.3760/cma.j.cn501113-20200418-00196. Chinese. PMID: 32536049.
Copy Download .nbib Format: NLM
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient.

Journal of diabetes and its complications

De Vincentis A, Antonelli-Incalzi R, Picardi A, Vespasiani-Gentilucci U.
PMID: 33642147
J Diabetes Complications. 2021 May;35(5):107891. doi: 10.1016/j.jdiacomp.2021.107891. Epub 2021 Feb 18.

No abstract available.

Cite
De Vincentis A, Antonelli-Incalzi R, Picardi A, et al. Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. J Diabetes Complications. 2021;35(5):107891doi: 10.1016/j.jdiacomp.2021.107891.
De Vincentis, A., Antonelli-Incalzi, R., Picardi, A., & Vespasiani-Gentilucci, U. (2021). Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. Journal of diabetes and its complications, 35(5), 107891. https://doi.org/10.1016/j.jdiacomp.2021.107891
De Vincentis, Antonio, et al. "Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient." Journal of diabetes and its complications vol. 35,5 (2021): 107891. doi: https://doi.org/10.1016/j.jdiacomp.2021.107891
De Vincentis A, Antonelli-Incalzi R, Picardi A, Vespasiani-Gentilucci U. Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient. J Diabetes Complications. 2021 May;35(5):107891. doi: 10.1016/j.jdiacomp.2021.107891. Epub 2021 Feb 18. PMID: 33642147.
Copy Download .nbib Format: NLM
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.

Alimentary pharmacology & therapeutics

Park JG, Jung J, Loomba R.
PMID: 34170539
Aliment Pharmacol Ther. 2021 Jul;54(2):216. doi: 10.1111/apt.16462.

No abstract available.

Cite
Park JG, Jung J, Loomba R. Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Aliment Pharmacol Ther. 2021;54(2):216doi: 10.1111/apt.16462.
Park, J. G., Jung, J., & Loomba, R. (2021). Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Alimentary pharmacology & therapeutics, 54(2), 216. https://doi.org/10.1111/apt.16462
Park, Jung Gil, et al. "Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply." Alimentary pharmacology & therapeutics vol. 54,2 (2021): 216. doi: https://doi.org/10.1111/apt.16462
Park JG, Jung J, Loomba R. Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Aliment Pharmacol Ther. 2021 Jul;54(2):216. doi: 10.1111/apt.16462. PMID: 34170539.
Copy Download .nbib Format: NLM
Showing 37 to 40 of 40 entries